Centiva Capital, LP Baxter International Inc Transaction History

Centiva Capital, LP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$39.98 - $47.68 $97,950 - $116,816	2,450 Added 36.26%	9,207 $419,000
Q1 2023 May 15, 2023	BUY	$37.58 - $52.57 $253,928 - $355,215	6,757 New	6,757 $274,000
Q3 2022 Nov 14, 2022	BUY	$53.86 - $66.8 $1.12 Million - $1.39 Million	20,800 New	20,800 $1.12 Million
Q2 2022 Aug 15, 2022	SELL	$63.83 - $80.0 $431,043 - $540,240	-6,753 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$76.85 - $89.45 $518,968 - $604,055	6,753 New	6,753 $524,000
Q4 2021 Feb 14, 2022	SELL	$74.57 - $87.19 $229,228 - $268,022	-3,074 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$73.77 - $83.61 $1.5 Million - $1.7 Million	-20,286 Reduced 86.84%	3,074 $247,000
Q2 2021 Aug 16, 2021	BUY	$80.5 - $88.01 $1.88 Million - $2.06 Million	23,360 New	23,360 $1.88 Million
Q1 2021 May 17, 2021	SELL	$76.38 - $86.03 $223,946 - $252,239	-2,932 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$75.39 - $82.36 $221,043 - $241,479	2,932 New	2,932 $235,000
Q3 2020 Nov 16, 2020	SELL	$78.33 - $90.73 $894,998 - $1.04 Million	-11,426 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$78.66 - $94.14 $898,769 - $1.08 Million	11,426 New	11,426 $984,000
Q1 2020 May 15, 2020	SELL	$71.57 - $93.3 $529,904 - $690,793	-7,404 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$76.7 - $88.45 $567,886 - $654,883	7,404 New	7,404 $619,000

998

450M

1.97M

3.04M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $17.5B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Centiva Capital, LP with notifications on news.